9 February 2018 - The White House is considering a plan to lower out-of-pocket costs for people in Medicare drug plans, who often pay inflated prices for their drugs.

When it comes to high drug prices, President Trump and members of Congress have been long on promises but short on action.

But that appears to be changing: The White House on Friday released a report recommending significant changes that would affect drug costs and the president’s budget proposal on Monday is expected to include some plans to expand drug coverage under Medicare. In addition, a spending bill passed by Congress on Friday included a provision that would accelerate closing a payment gap in Medicare for prescription drugs.

Read New York Times article